FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2566254116> ?p ?o ?g. }

• W2566254116 abstract "Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PAThe endothelium is an attractive gene therapy target for metastatic cancer, providing access to systemic tumors. Previous work has focused on either viral entry/attachment (transductional targeting), or cell type specific enhancer promoter vector transgene expression regulation (transcriptional targeting). While previous studies demonstrated endothelial targeting, the tumor wide extent and transgene expression level quantification have been uncertain. Indeed, obtaining robust and stringent tumor expression has been challenging due to: insufficient transduction, focal rather than widespread intratumoral vascular expression, viral particle liver sequestration, and host preformed immunity. We developed a set of adenoviral vectors, containing 3 kb of the human ROBO4 enhancer/promoter, that are expressed at high levels throughout tumor vasculature. We now have three vectors representing four tiers of genetic modification. Transgenes encoding fluorescent proteins allowed us to quantify endothelial expression frequency by image analysis, and expression level using whole tissue Western blotting. Our first vector was Ad5.ROBO4. Compared with Ad5.CMV, Ad5.ROBO4 evidenced complete retargeting from hepatocytes to low-level expression in host organ and tumor endothelial cells. Warfarin-mediated hepatocyte detargeting produced a striking increase in tumor and bone marrow sinusoidal endothelial expression, without change in other host organs. Our second vector is Ad.RGD.H5/H3.ROBO4. Insertion of a cyclized RGD peptide in the fiber/knob HI loop engages enhanced tumor endothelial transduction via αv/β3 and αv/β5. Swapping hexon hypervariable regions responsible for Ad Type 5-Factor X binding with corresponding regions from serotype 3 enables marked diminution of hepatocyte sequestration. Use of the ROBO4 enhancer promoter produces high-level pan-intratumoral vascular expression particularly in cancers with markedly elevated VEGF production, such as orthotopic and metastatic renal cell carcinoma, orthotopic colonic liver metastases, and prostate cancer bone, brain, and liver metastases. Most striking, was enhancement of Ad.RGD.H5/H3.ROBO4 vector expression within interior tumor regions undergoing hypoxic necrosis; regions notoriously resistant to radiation or chemotherapies. Our third vector contains a polycistronic array, enabling triple transgene expression from a single vector within the tumor vasculature. Thus, we have panel of endothelial-targeted vectors with distinctive vascular tropism for use in cancers metastatic to individual host organs. These vectors enable expression of a palette of transgenes that can manipulate the tumor microenvironment to achieve metastatic growth inhibition alone, or “staggered” with chemo- or irradiation therapies.Note: This abstract was not presented at the meeting.Citation Format: Zhi Hong Lu, Sergey Kaliberov, Lyudmila Kaliberova, Rebecca E. Sohn, Yingqui Du, David T. Curiel, Jeffrey M. Arbeit. Creation of endothelial-targeted adenoviral vectors for genetic engineering of the metastatic tumor microenvironment. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 5210. doi:10.1158/1538-7445.AM2015-5210" @default.
• W2566254116 created "2017-01-06" @default.
• W2566254116 creator A5006450491 @default.
• W2566254116 creator A5009978389 @default.
• W2566254116 creator A5022987623 @default.
• W2566254116 creator A5025782979 @default.
• W2566254116 creator A5027836042 @default.
• W2566254116 creator A5050203492 @default.
• W2566254116 creator A5059960929 @default.
• W2566254116 date "2015-08-01" @default.
• W2566254116 modified "2023-09-27" @default.
• W2566254116 title "Abstract 5210: Creation of endothelial-targeted adenoviral vectors for genetic engineering of the metastatic tumor microenvironment" @default.
• W2566254116 doi "https://doi.org/10.1158/1538-7445.am2015-5210" @default.
• W2566254116 hasPublicationYear "2015" @default.
• W2566254116 type Work @default.
• W2566254116 sameAs 2566254116 @default.
• W2566254116 citedByCount "0" @default.
• W2566254116 crossrefType "proceedings-article" @default.
• W2566254116 hasAuthorship W2566254116A5006450491 @default.
• W2566254116 hasAuthorship W2566254116A5009978389 @default.
• W2566254116 hasAuthorship W2566254116A5022987623 @default.
• W2566254116 hasAuthorship W2566254116A5025782979 @default.
• W2566254116 hasAuthorship W2566254116A5027836042 @default.
• W2566254116 hasAuthorship W2566254116A5050203492 @default.
• W2566254116 hasAuthorship W2566254116A5059960929 @default.
• W2566254116 hasConcept C102230213 @default.
• W2566254116 hasConcept C104317684 @default.
• W2566254116 hasConcept C111599444 @default.
• W2566254116 hasConcept C111936080 @default.
• W2566254116 hasConcept C123012128 @default.
• W2566254116 hasConcept C150194340 @default.
• W2566254116 hasConcept C15152581 @default.
• W2566254116 hasConcept C153911025 @default.
• W2566254116 hasConcept C202751555 @default.
• W2566254116 hasConcept C203014093 @default.
• W2566254116 hasConcept C2776107976 @default.
• W2566254116 hasConcept C3020616263 @default.
• W2566254116 hasConcept C32470452 @default.
• W2566254116 hasConcept C40767141 @default.
• W2566254116 hasConcept C502942594 @default.
• W2566254116 hasConcept C54355233 @default.
• W2566254116 hasConcept C55493867 @default.
• W2566254116 hasConcept C86803240 @default.
• W2566254116 hasConceptScore W2566254116C102230213 @default.
• W2566254116 hasConceptScore W2566254116C104317684 @default.
• W2566254116 hasConceptScore W2566254116C111599444 @default.
• W2566254116 hasConceptScore W2566254116C111936080 @default.
• W2566254116 hasConceptScore W2566254116C123012128 @default.
• W2566254116 hasConceptScore W2566254116C150194340 @default.
• W2566254116 hasConceptScore W2566254116C15152581 @default.
• W2566254116 hasConceptScore W2566254116C153911025 @default.
• W2566254116 hasConceptScore W2566254116C202751555 @default.
• W2566254116 hasConceptScore W2566254116C203014093 @default.
• W2566254116 hasConceptScore W2566254116C2776107976 @default.
• W2566254116 hasConceptScore W2566254116C3020616263 @default.
• W2566254116 hasConceptScore W2566254116C32470452 @default.
• W2566254116 hasConceptScore W2566254116C40767141 @default.
• W2566254116 hasConceptScore W2566254116C502942594 @default.
• W2566254116 hasConceptScore W2566254116C54355233 @default.
• W2566254116 hasConceptScore W2566254116C55493867 @default.
• W2566254116 hasConceptScore W2566254116C86803240 @default.
• W2566254116 hasLocation W25662541161 @default.
• W2566254116 hasOpenAccess W2566254116 @default.
• W2566254116 hasPrimaryLocation W25662541161 @default.
• W2566254116 hasRelatedWork W1480855956 @default.
• W2566254116 hasRelatedWork W1589534094 @default.
• W2566254116 hasRelatedWork W1963689274 @default.
• W2566254116 hasRelatedWork W1967075422 @default.
• W2566254116 hasRelatedWork W1970856410 @default.
• W2566254116 hasRelatedWork W1974613901 @default.
• W2566254116 hasRelatedWork W1976829669 @default.
• W2566254116 hasRelatedWork W1997404047 @default.
• W2566254116 hasRelatedWork W2005871567 @default.
• W2566254116 hasRelatedWork W2026201947 @default.
• W2566254116 hasRelatedWork W2033141783 @default.
• W2566254116 hasRelatedWork W2038325417 @default.
• W2566254116 hasRelatedWork W2039101384 @default.
• W2566254116 hasRelatedWork W2087153788 @default.
• W2566254116 hasRelatedWork W2162746641 @default.
• W2566254116 hasRelatedWork W2163427879 @default.
• W2566254116 hasRelatedWork W2167188379 @default.
• W2566254116 hasRelatedWork W2804238454 @default.
• W2566254116 hasRelatedWork W3138833031 @default.
• W2566254116 hasRelatedWork W337405202 @default.
• W2566254116 isParatext "false" @default.
• W2566254116 isRetracted "false" @default.
• W2566254116 magId "2566254116" @default.
• W2566254116 workType "article" @default.